CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Dr. James P. Allison, CRI Scientific Director, Awarded 2018 Nobel Prize along with Dr. Tasuku Honjo

    Dr. Allison’s discoveries and determination led to the development of the first FDA-approved checkpoint immunotherapy

    October 1, 2018| Arthur N. Brodsky, PhD
  • Former CRI Grantee Dr. Lieping Chen Named a “2018 Giant of Cancer Care in Immuno-Oncology”

    Dr. Lieping Chen's work helped pave the way for the development of the PD-1/PD-L1 checkpoint immunotherapies that…

    July 20, 2018| Arthur N. Brodsky, PhD
  • AACR18 Update: Lloyd J. Old Award, Overcoming Immunotherapy Resistance, and the Importance of Dendritic Cells

    Day 4 at AACR18 was a special day for CRI’s Dr. Antoni Ribas, and highlighted his and…

    April 18, 2018| Arthur N. Brodsky, PhD
  • Immunotherapy is Here to Stay: Looking Back at this Year’s Breakthroughs

    Important immunotherapy breakthroughs benefited patients immensely in 2017 and paved the way for even more advances in…

    December 28, 2017| Arthur N. Brodsky, PhD
  • CRI Congratulates 2016 Lasker Award Winners

    The Albert and Mary Lasker Foundation announced the 2016 recipients of the prestigious Lasker Awards, and CRI congratulates Charles…

    September 14, 2016| Arthur N. Brodsky, PhD
  • CRI Scientist Receives Russian Federation National Award

    Sergei Nedospasov, PhD, D.Sc., was honored for his contributions to the molecular mediators of immunity, including work…

    July 13, 2016| Alexandra Mulvey
  • #AACR16 Update: The Cancer Research Institute’s Impact on Immunotherapy

    Since our founding in 1953, the Cancer Research Institute has pioneered the field of cancer immunology, and…
    April 20, 2016| Arthur N. Brodsky, PhD
  • CRI Scientific Advisory Council Member Elected NAI Fellow

    Pramod K. Srivastava, MD, PhD, a CRI Scientific Advisory Council member, was elected a Fellow in the National…

    December 15, 2015| Arthur N. Brodsky, PhD
  • CRI’s James Allison to Receive Prestigious Lasker Award

    The Lasker Foundation announced today that James P. Allison, PhD, director of CRI’s Scientific Advisory Council, is…

    September 8, 2015| Matthew Tontonoz
Previous Page
1 2 3
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute